Another example is the CRE hypotheses for increased fatty acid oxidation enzymes
treated with STK295900 were arrested in G2 phase without activation of DNA damage checkpoint. These findings may therefore suggest a potential development of symmetric bibenzimidazole as a chemotherapeutic agent. In…